These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1083 related items for PubMed ID: 28679558

  • 1. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.
    J Am Heart Assoc; 2017 Jul 05; 6(7):. PubMed ID: 28679558
    [Abstract] [Full Text] [Related]

  • 2. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M.
    Clin J Am Soc Nephrol; 2015 Feb 06; 10(2):205-14. PubMed ID: 25605700
    [Abstract] [Full Text] [Related]

  • 3. Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.
    Colbert G, Jain N, de Lemos JA, Hedayati SS.
    Clin J Am Soc Nephrol; 2015 Mar 06; 10(3):515-29. PubMed ID: 25403922
    [Abstract] [Full Text] [Related]

  • 4. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S, Winkel P, Gøtze JP, Kastrup J, Gluud C, Kolmos HJ, Kjøller E, Jensen GB, Hansen JF, Hildebrandt P, Hilden J, CLARICOR Trial Group.
    Eur J Prev Cardiol; 2014 Oct 06; 21(10):1275-84. PubMed ID: 23723326
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular Determinants of Mortality in Advanced Chronic Kidney Disease.
    Lankinen R, Hakamäki M, Metsärinne K, Koivuviita NS, Pärkkä JP, Hellman T, Kartiosuo N, Raitakari OT, Järvisalo MJ.
    Am J Nephrol; 2020 Oct 06; 51(9):726-735. PubMed ID: 32777781
    [Abstract] [Full Text] [Related]

  • 6. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
    Chaikriangkrai K, Nabi F, Mahmarian JJ, Chang SM.
    Int J Cardiovasc Imaging; 2015 Dec 06; 31(8):1619-26. PubMed ID: 26243534
    [Abstract] [Full Text] [Related]

  • 7. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S, Larson T, Cauliez B, Bauer F, Dumont A, Le Roy F, Hanoy M, Fréguin-Bouilland C, Godin M, Guerrot D.
    PLoS One; 2016 Dec 06; 11(8):e0159914. PubMed ID: 27548064
    [Abstract] [Full Text] [Related]

  • 8. Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.
    Kuller LH, Lopez OL, Gottdiener JS, Kitzman DW, Becker JT, Chang Y, Newman AB.
    J Am Heart Assoc; 2017 Jul 22; 6(7):. PubMed ID: 28735291
    [Abstract] [Full Text] [Related]

  • 9. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA.
    Am J Kidney Dis; 2011 Nov 22; 58(5):717-28. PubMed ID: 21820220
    [Abstract] [Full Text] [Related]

  • 10. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
    Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J.
    Arterioscler Thromb Vasc Biol; 2014 Aug 22; 34(8):1770-7. PubMed ID: 24876355
    [Abstract] [Full Text] [Related]

  • 11. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S, Dimko M, Galani A, Coppola B, Innico G, Frassetti N, Mazzei ED, Mariotti A.
    Ren Fail; 2015 Mar 22; 37(2):254-61. PubMed ID: 25394527
    [Abstract] [Full Text] [Related]

  • 12. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Pascual-Figal D, Galisteo-Almeda L, Januzzi JL.
    Clin Cardiol; 2015 Feb 22; 38(2):106-13. PubMed ID: 25663560
    [Abstract] [Full Text] [Related]

  • 13. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
    Bansal N, Zelnick L, Shlipak MG, Anderson A, Christenson R, Deo R, deFilippi C, Feldman H, Lash J, He J, Kusek J, Ky B, Seliger S, Soliman EZ, Go AS, CRIC Study Investigators.
    Clin Chem; 2019 Nov 22; 65(11):1448-1457. PubMed ID: 31578216
    [Abstract] [Full Text] [Related]

  • 14. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
    Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, Zhang X, Roy JA, Lustigova E, Nessel L, Ford V, Raj D, Porter AC, Soliman EZ, Wright JT, Wolf M, He J, CRIC Investigators.
    JAMA Cardiol; 2017 Jun 01; 2(6):635-643. PubMed ID: 28329057
    [Abstract] [Full Text] [Related]

  • 15. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, Lamb EJ.
    Am J Kidney Dis; 2005 Oct 01; 46(4):610-20. PubMed ID: 16183415
    [Abstract] [Full Text] [Related]

  • 16. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L, de Jong PE, Hillege HL, Lambers Heerspink HJ, van Pelt LJ, Kootstra JE, Bakker SJ, Gansevoort RT, PREVEND study group.
    Eur Heart J; 2012 Sep 01; 33(18):2272-81. PubMed ID: 22740385
    [Abstract] [Full Text] [Related]

  • 17. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 18. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
    Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, Ix JH, Lloyd-Jones D, Omland T, Sabatine MS, Schiller NB, Shlipak MG, Skali H, Takeuchi M, Vittinghoff E, Whooley MA.
    J Am Heart Assoc; 2015 Jul 06; 4(7):. PubMed ID: 26150476
    [Abstract] [Full Text] [Related]

  • 19. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T, Kimura T, Yasuda K, Sasaki K, Obi Y, Rakugi H, Isaka Y.
    Clin Exp Nephrol; 2017 Apr 06; 21(2):333-341. PubMed ID: 27178276
    [Abstract] [Full Text] [Related]

  • 20. The Association of Coronary Artery Calcium With Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.
    Handy CE, Desai CS, Dardari ZA, Al-Mallah MH, Miedema MD, Ouyang P, Budoff MJ, Blumenthal RS, Nasir K, Blaha MJ.
    JACC Cardiovasc Imaging; 2016 May 06; 9(5):568-576. PubMed ID: 26970999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.